EARNINGS PREVIEW: Europe Pharma's 3Q Results Set To be Mixed.
October 15, 2010
TAKING THE PULSE: European pharmaceutical companies are set to present mixed third-quarter performances in coming days, with analysts and investors expecting players to elaborate further on planned restructuring and how some will handle imminent sales declines due to patent expiries in coming years.
All face regulatory hurdles and pricing pressures following health care reforms in the U.S. and Europe that leave many few options other than to pursue new avenues of growth and adapt to the post-blockbuster era, making sense of, and hopefully profiting from, a vast array of new scientific breakthroughs and technologies.
Link:
http://www.nasdaq.com/aspx/stock-market-news-story.aspx?storyid=201010151018dowjonesdjonline000455&title=earnings-preview-europe-pharmas-3q-results-set-to-be-mixed
great news, page-69
Add AVE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $7.923M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 54 | 86239613 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 63389028 | 18 |
View Market Depth
| Last trade - 12.26pm 31/07/2024 (20 minute delay) ? |
| AVE (ASX) Chart |
Day chart unavailable